申请人:Isis Pharmaceuticals Inc.
公开号:US20040023383A1
公开(公告)日:2004-02-05
Antisense compounds, compositions and methods are provided for modulating the expression of resistin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding resistin. Methods of using these compounds for modulation of resistin expression and for treatment of diseases associated with expression of resistin are provided.
提供了用于调节抗性蛋白表达的反义化合物、组合物和方法。这些组合物包括针对编码抗性蛋白的核酸的反义化合物,特别是反义寡核苷酸。提供了利用这些化合物调节抗性蛋白表达以及治疗与抗性蛋白表达相关疾病的方法。